GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Return 49.13%
This Quarter Return
+18.82%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$337M
AUM Growth
-$4.48M
Cap. Flow
-$37.8M
Cap. Flow %
-11.21%
Top 10 Hldgs %
43.87%
Holding
79
New
19
Increased
11
Reduced
20
Closed
23

Top Buys

1
ZGNX
Zogenix, Inc.
ZGNX
$17.5M
2
IMMU
Immunomedics Inc
IMMU
$10.4M
3
XLRN
Acceleron Pharma Inc.
XLRN
$9.7M
4
TMO icon
Thermo Fisher Scientific
TMO
$9.46M
5
GBT
Global Blood Therapeutics, Inc.
GBT
$7.76M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
$15.5M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
$11.2M
3
PBYI icon
Puma Biotechnology
PBYI
$10.2M
4
ENDP
Endo International plc
ENDP
$8.38M
5
AVXS
AveXis, Inc. Common Stock
AVXS
$8.27M

Sector Composition

1 Healthcare 80.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GWPH
26
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.08M 1.08%
50,000
-75,000
-60% -$7.61M
AIMT
27
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$4.96M 1.05%
200,000
-50,000
-20% -$1.24M
BMY icon
28
Bristol-Myers Squibb
BMY
$95B
$4.78M 1.02%
+75,000
New +$4.78M
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.93B
$4.54M 0.96%
+100,000
New +$4.54M
JUNO
30
DELISTED
Juno Therapeutics, Inc.
JUNO
$4.49M 0.95%
100,000
-175,000
-64% -$7.85M
MRK icon
31
Merck
MRK
$210B
$4.16M 0.88%
+68,120
New +$4.16M
ALNY icon
32
Alnylam Pharmaceuticals
ALNY
$59.4B
$4.11M 0.87%
+35,000
New +$4.11M
INCY icon
33
Incyte
INCY
$16.7B
$4.09M 0.87%
+35,000
New +$4.09M
VRAY
34
DELISTED
ViewRay, Inc.
VRAY
$4.03M 0.86%
700,000
-50,000
-7% -$288K
FXB icon
35
Invesco CurrencyShares British Pound Sterling Trust
FXB
$90.3M
$3.92M 0.83%
30,100
-20,800
-41% -$2.71M
NEOS
36
DELISTED
Neos Therapeutics, Inc
NEOS
$3.66M 0.78%
400,000
-100,000
-20% -$915K
AERI
37
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$3.65M 0.77%
+75,000
New +$3.65M
RARX
38
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$3.43M 0.73%
235,000
+150,000
+176% +$2.19M
FOLD icon
39
Amicus Therapeutics
FOLD
$2.47B
$3.02M 0.64%
+200,000
New +$3.02M
KDMN
40
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.85M 0.6%
+850,000
New +$2.85M
RIGL icon
41
Rigel Pharmaceuticals
RIGL
$720M
$2.79M 0.59%
110,000
– –
BCRX icon
42
BioCryst Pharmaceuticals
BCRX
$1.74B
$2.62M 0.56%
500,000
-175,000
-26% -$917K
ICPT
43
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.03M 0.43%
+35,000
New +$2.03M
PTCT icon
44
PTC Therapeutics
PTCT
$4.61B
$2M 0.42%
100,000
-100,000
-50% -$2M
IRIX icon
45
IRIDEX
IRIX
$22.4M
$1.87M 0.4%
199,519
-50,481
-20% -$473K
NUVA
46
DELISTED
NuVasive, Inc.
NUVA
$1.66M 0.35%
30,000
-70,000
-70% -$3.88M
EXEL icon
47
Exelixis
EXEL
$10.1B
$1.3M 0.28%
+53,500
New +$1.3M
DCPH
48
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.22M 0.26%
+64,410
New +$1.22M
NBRV
49
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$983K 0.21%
+480
New +$983K
QTNT
50
DELISTED
Quotient Limited Ordinary Shares
QTNT
$924K 0.2%
4,686
-2,814
-38% -$555K
1
2
3 4